Multidrug resistance analysis in lymphoproliferative disease of large granular lymphocytes

British Journal of Haematology

Volumn 100, Issue 3, 1998, Pages 509-515

  Lamy, Thierry ^a   Drenou, Bernard ^b   Fardel, Olivier ^b   Amiot, Laurence ^b   Grulois, Isabelle ^b   Le Prise, Pierre Yves ^b   Loughran Jr , Thomas P ^a   Fauchet, Renee ^b  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b RENNES UNIVERSITY HOSPITAL   (France)

Author keywords

Large granular lymphocytes; P110; PgP

Indexed keywords

VERAPAMIL;

ADULT; AGED; ANALYTIC METHOD; ARTICLE; CANCER SURVIVAL; CELL PROTECTION; CELL SURVIVAL; CLINICAL ARTICLE; CYTOTOXICITY; FEMALE; FLOW CYTOMETRY; HUMAN; KILLER CELL; LARGE GRANULAR LYMPHOCYTE; LYMPHOPROLIFERATIVE DISEASE; MALE; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; REMISSION; TREATMENT FAILURE;

ADULT; AGED; ANTIGENS, CD; DRUG RESISTANCE, MULTIPLE; FEMALE; GENES, MDR; GRANULOCYTES; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOPROLIFERATIVE DISORDERS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; P-GLYCOPROTEIN; T-LYMPHOCYTES; TUMOR MARKERS, BIOLOGICAL; VAULT RIBONUCLEOPROTEIN PARTICLES;

EID: 0031839760     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1998.00606.x     Document Type: Article

References (42)

1. Bommhard, U., Cerottini, J.C. & McDonald, H.P., (1994) Heterogeneity in P-glycoprotein (multidrug resistance) activity among murine peripheral T cells: correlation with surface phenotype and effector function. European Journal of Immunology, 24, 2974-2981.
2. Broxterman, H.J., Sonneveld, P., Feller, N., Ossenkoppele, G.J., Wahrer, D.C.R., Eekman, C.A., Schoester, M., Lankelma, J., Pinedo, H.M., Lowenberg, B. & Schuurhuis, G.J. (1946) Quality control of multi-drug resistance assays in adult acute leukemia: correlation between assays for P-glycoprotein and activity. Blood, 87, 4809-4816.
3. Chaudhary, P.M., Mechetner, E.B. & Roninson, I.B. (1992) Expression and activity of the multidrug resistance P-glycoprotein in human peripheral blood lymphocytes. Blood, 80, 2735-2739.
4. Chaudhary, P.M. & Roninson, I.B. (1991) Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells. Cell, 66, 85-94.
5. Chen, C.J., Chin, J.E., Veda, K., Clark, D.P., Pastan, L., Gottesman, M.M. & Roninson, I.B. (1986) International duplication and homology with bacterial transport proteins in the MDR-1 (P-glycoprotein) gene from multi-drug resistant human cells. Cell, 47, 381-189.
6. Chong, A.S.F., Markham, P.N., Gebel, H.M., Bines, S.D. & Coon, J.S. (1993) Diverse multidrug-resistance modification agents inhibit cytolytic activity of natural killer cells. Cancer Immunology and Immunotherapy, 36, 133-139.
7. Cole, S.P.C., Bhardwaj, G., Gerlach, J.M., Mackie, J.E., Grant, C.E., Almquist, K.C., Stewart, A.J., Kurz, E.U., Duncan, A.M.V. & Deeley, R.G. (1992) Overexpression of a transporter in a multidrug-resistant human lung cancer line line. Science, 258, 1650-1654.
8. Del Poeta, G., Stasi, R., Aronica, G., Venditti, A., Cox, M.C., Bruno, A., Buccisano, F., Masi, M., Tribalto, M., Amadori, S. & Papa, G. (1996) Clinical relevance of P-glycoprotein expression in de novo acute myeloid leukemia. Blood, 87, 1997-2004.
9. Dhodapkar, M.V., Li, C.Y., Lust, J.A., Tefferi, A. & Phyliky, R.L. (1994) Clinical spectrum of clonal proliferations of T-large granular lymphocytes: a T-cell clonopathy of undetermined significance? Blood, 84, 1620-1627.
10. Dietel, M., Arps, H., Lage, H. & Niendorf, A. (1990) Membrane vesicle formation due to acquired mitoxantrone resistance in human gastric carcinoma cell lines EPG 85-257. Cancer Research, 50, 6100-6106.
11. + non-Hodgkin lymphomas with an aggressive behavior related to multidrug resistance. Blood, 89, 2965-2974.
12. Endicot, J.A. & Ling, V. (1989) The biochemistry of P-glycoprotein mediated multidrug resistance. Annual Review of Biochemistry, 58, 137-171.
13. Feller, N., Kuiper, C.M., Laukelma, J., Ruhdal, J.K., Scheper, R.J., Pinedo, H.M. & Broxterman, H.J. (1995) Functional detection of MDR1/P170 and MRP/P190 mediated multidrug resistance in tumors cells by flow cytometry. British Journal of Cancer, 72, 543-549.
14. Flens, A.F., Izquierdo, M.A., Scheffer, G.L., Fritz, J.M., Meijer, C.J.L.M., Scheper, R.J. & Zaman, G.J.R. (1994) Immunochemical detection of the multidrug resistance-associated protein MRP in human multidrug-resistant tumor cells by monoclonal antibodies. Cancer Research, 54, 4557-4563.
15. Fojo, A.T., Akiyana, S.I., Gottesman, M.M. & Pastan, I. (1985) Reduced drug accumulation in multiple drug-resistant KB carcinoma cell lines. Cancer Research, 45, 3002-3007.
16. + aggressive variant of large granular lymphocyte leukemia. Blood, 84, 2315-2321.
17. Goasguen, J., Lamy, T., Bergeron, C., Ly Sunaram, B., Mordelet, E., Gorre, G., Dossot, J.M., Le Gall, E., Grosbois, B., Le Prise, P.Y. & Fauchet, R. (1996) Multifactorial drug resistance phenomenon in acute leukemia: impact of P170-MDR1, LRP56 protein, glutathion-transferases and metallothionein systems on clinical outcome. Leukemia and Lymphoma, 23, 567-576.
18. Goldstein, L.J., Galski, H., Fojo, A., Willingham, M., Lai, S.L., Gazdar, A., Pirker, R., Creen, A., Cust, W., Brodeur, G.M., Luber, M., Cossman, J., Gottesman, M.M. & Pastan, I. (1989) Expression of a multidrug resistance gene in human cancers. Journal of the National Cancer Institute, 81, 116-124.
19. + T cells: a role in cytotoxic effector function. Journal of Clinical Immunology, 12, 451-458.
20. Izquierdo, M.A., Shoemaker, R.H., Flens, M.J., Scheffer, G.L., Wu, L., Prather, T.R. & Schepper, R.J. (1996) Overlapping phenotypes of multidrug resistance among panels of human cancer-cell lines. International Journal of Cancer, 65, 230-1393.
21. Lamy, T., Drenou, B., Grulois, I., Fardel, O., Jacquelinet, C., Goasgen, J., Dauriac, C., Amiot, L., Bernard, M., Fauchet, R. & Le Prise, P.Y. (1995) Multi-drug resistance (MDR) activity in acute leukemia determined by rhodamine 123 efflux assay. Leukemia, 9, 1549-1555.
22. - cases. Blood, 86, 2329.
23. List, A.F. (1993) Multidrug resistance: clinical relevance in acute leukemia. Oncology, 7, 23-30.
24. List, A.F., Spier, C.S., Grogan, T.M., Johnson, C. Roe, D.J., Greer, J.P., Wolff, S.N., Broxterman, H.J., Scheffer, G.L., Scheper, R.J. & Dalton, W.S. (1996) Overexpression of the major vault transport protein lung resistance protein predicts outcome in acute myeloid leukemia. Blood, 87, 2464-2469.
25. Loughran, T.P., Jr (1993) Clonal diseases of large granular lymphocytes. Blood, 82, 1-14.
26. MacIntyre, E., d'Auriol, L., Amesland, F., Loiseau, P., Chen, L., Boumsell, L., Galibert, F. & Sigaux, F. (1989) Analysis of junctional diversity in the preferential V-J rearrangement for fresh T-acute lymphoblastic leukemia cells by in vitro amplification and direct sequencing. Blood, 74, 2053-2061.
27. Marie, J.P., Perrot, J.Y., Chevillard, S., Huet, S., Faussat, A.M. & Robert, J. (1996) The French multicentric evaluation of MDR phenotype in leukemia: conclusions and guidelines. Blood, 88, (Suppl. 1), 664a.
28. McKenna, S.L. & Padua, R.A. (1997) Multidrug resistance in leukaemia. British Journal of Haematology, 96, 659-674.
29. Muller, M.R., Lenmartz, K., Nowrousian, M.R., Dux, R., Tsuruo, T., Rajewesky, M.F. & Seeber, S. (1994) Improved flow cytometry detection of low P-glycoprotein expression in leukemic blasts by histogram subtraction analysis. Leukemia Research, 15, 64-72.
30. Noonan, K.E., Beck, C., Hozmayer, T.A., Chin, J.E., Wunder, J.S., Andrulis, I.L., Gazdar, A.F., Willman, C.L., Griffith, B., Von Hoff, D.D. & Roninson, I.B. (1990) Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction. Proceedings of the National Academy of Sciences of the United States of America, 87, 7160-7164.
31. Ohno, Y., Amakawa, R., Pukuhara, S., Huang, C.R., Kamesaki, H., Amano, H., Imanaka, T., Takahashi, Y. Arita, Y. Uchiyama, T., Kita, K. & Miwa, H. (1989) Acute transformation of chronic large granular lymphocyte leukemia associated with additional chromosome abnormality. Cancer, 64, 63-67.
32. Ohno, T., Kanoh, T., Arita, Y., Fujii, H., Kuribayashi, K., Masuda, T., Horiguchi, Y. Taniwaki, M., Nosaka, T., Hatanaka, M. & Uchino, U. (1988) Fulminant clonal expansion of large granular lymphocytes: characterization of their morphology, phenotype, genotype, and function. Cancer, 62, 1918-1927.
33. Oshimi, K. (1988) Granular lymphocyte proliferative disorders: report of 12 cases and review of the literature. Leukemia, 2, 617-627.
34. Pastan, L. & Gottesman, M.M. (1987) Multiple-drug resistance in human cancer. New England Journal of Medicine, 316, 1388-1393.
35. Raghu, G., Park, S.W., Roninson, I.B. & Metcheter, E.B. (1996) Monoclonal antibodies against P-glycoprotein and MDR1 gene product inhibit interleukin 2 release from PHA-activated lymphocytes. Experimental Hematotogy. 24, 1258-1264.
36. Scheper, R.J., Broxterman, H.J., Scheffer, G.L., Kaaijk, P., Dalton, W.S., Van Heijningen, T.H.M., Van Kalken, C.K., Slovak, M.L., De Vries, E.G.E., Van der Valk, P., Meijer, C.J.L.M. & Pinedo, H.M. (1993) Overexpression of a Mr 110.000 vesicular in non P-glycoprotein-mediated multidrug resistance. Cancer Research, 53, 1475-1479.
37. Semenzato, G., Pandolfi, F., Chiesesi, T., De Rossi, G., Pizzolo, G., Zambello, R., Trentin, L., Agostini, C., Dini, E., Vespignani, M., Cafaro, A., Paqualetti, D., Giubellino, M.C., Mignone, N. & Foa, R. (1987) The lymphoproliferative disease of granular lymphocytes: a heterogeneous disorder ranging from indolent to aggressive conditions. Cancer, 60, 2971-2978.
38. Semenzato, G., Zambello, R., Starkebaum, G., Oshimi, K. & Loughran, T.P., Jr (1997) The lymphoproliferative disease of granular lymphocytosis: updated criteria for diagnosis. Blood, 89, 256-260.
39. Webb, M., Raphael, C.L., Asbahr, M., Erber, W.N. & Meyer, B.F. (1996) The detection of rhodamine 123 efflux at low levels of drug resistance. British Journal of Haematology, 93, 650-655.
40. Weisburg, J.H., Curcio, M., Caron, P.C., Raghu, G., Mechetner, E.B., Roepe, P.D. & Scheinberg, D.A. (1996) The multidrug resistance phenotype confers immunological resistance. Journal of Experimental Medicine, 183, 2699-2704.
41. Wood, P., Burgess, R., Mac Gregor, A. & Liu Yin, J.A. (1994) P-glycoprotein expression on acute myeloid leukaemia blast cells at diagnosis predicts response to chemotherapy and survival. British Journal of Haematology, 87, 509-514.
42. Yamamoto, T., Iwasaki, T., Watanabe, N., Oshimi, K., Naito, M., Tsuruo, T. & Kobayashi, Y. (1993) Expression of multidrug resistance P-glycoprotein on peripheral mononuclear cells of patients with granular lymphocyte proliferations disorders. Blood, 81, 1342-1346.